Page 195 - Programme book for The International Liver Congress 2015, EASL ILC 2015

YI P0439 HUMAN 3D HEPATIC CO-CULTURE MODEL FOR INVITRO ePOSTERS
YI P0440 DRUG-INDUCED FIBROSIS TESTING
YI P0441 Sofia B. Leite*, Tiffany Roosens, Inge Mannaerts, Adil E. Taghdouini,
YI P0442 Mustapha Najimi, Etienne Sokal, Christophe Chesne,
YI P0443 Leonardus A. van Grunsven, Belgium

YI P0444 ANTIFIBROTIC EFFICACY OF TGF-BETA RECEPTOR
YI P0445 ANTAGONIST IN PRECISION-CUT HUMAN AND RAT LIVER
SLICES
YI P0446 Theerut Luangmonkong*, Rick Mutsaers, Dorenda Oosterhuis,
Peter Olinga, The Netherlands

TACKLING FIBROSIS USING TGF-B2 TARGETED AONS
IN VIVO
Anne Dropmann*, Hanna Korhonen, Frank Jaschinski, Michel Janicot,
Nadja Meindl-Beinker, Steven Dooley, Germany

UDCA-LPE MODULATES DIFFERENT SIGNALING
PATHWAYS INVOLVED IN HEPATIC FIBROGENESIS
Jie Su*, Walee Chamulitrat, Wolfgang Stremmel, Anita Pathil, Germany

HYPERAMMONEMIA ACTIVATES HUMAN HEPATIC
STELLATE CELLS AND IS A TARGET FOR TREATMENT OF
PORTAL HYPERTENSION
Francesco De Chiara*, Rajiv Jalan, Vairappan Balasubramaniyan,
Fausto Andreola, Massimo Malago’, Massimo Pinzani,
Rajeshwar P. Mookerjee, Krista Rombouts, The United Kingdom

THE HIPPO PATHWAY EFFECTOR YAP CONTROLS MOUSE
HEPATIC STELLATE CELL ACTIVATION
Inge Mannaerts*, Sofia B. Leite, Stefaan Verhulst, Lien F. Thoen,
Sofie Claerhout, Georg Halder, Leonardus A. van Grunsven, Belgium

OBETICHOLIC ACID, AN FXR AGONIST, REDUCES HEPATIC
FIBROSIS IN A RAT MODEL OF TOXIC CIRRHOSIS
Len D. Verbeke*, Inge Mannaerts, Robert Schierwagen, Sabine Klein,
Ingrid Vander Elst, Petra Windmolders, Ricard Farre, Mathias Wenes,
Massimiliano Mazzone, Frederik Nevens, Leo A. van Grunsven,
Jonel Trebicka, Wim Laleman, Belgium

INHIBITORY EFFECT OF DIETARY CAPSAICIN ON LIVER
FIBROSIS IN MICE
Shanna Bitencourt, Leslie Stradiot*, Stefaan Verhulst, Lien Thoen,
Inge Mannaerts, Leo A. van Grunsven, Belgium

Vienna, Austria • April 22–26, 2015 195